Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LFCN Block Dose-Distribution Study
NCT03138668Phase 2Completed
- Sponsor
- Zealand University Hospital
- Start
- May 2017
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in postoperative pain, sponsored by Zealand University Hospital. Started May 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03138668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03138668.